Vandenbogaerde A L, Geboes K R, Cuveele J F, Agostinis P M, Merlevede W J, De Witte P A
Laboratorium voor Farmaceutische Biologie en Fytofarmacologie, Katholieke Universiteit te Leuven, Belgium.
Anticancer Res. 1996 Jul-Aug;16(4A):1619-25.
The in vivo antitumour activity of the natural photosensitizer hypericin was evaluated. Athymic nude mice xenografted with A431 cells were intraperitoneally administered with different hypericin doses and the tumours were locally irradiated 2 h later with white light (180 J/cm2) using a cold light source. When treatment was started one day after tumour inoculation, a dose-dependent antitumour effect was observed in light-treated animals. Complete inhibition of the tumour growth was achieved with 2.5 mg/kg hypericin. When the efficacy of a single hypericin dose (5 mg/kg) followed by a single light treatment on established tumours (60 mm3) was investigated, an 80% reduction in tumour mass was seen. Furthermore, an accumulation of the photosensitizer in A431 xenografts was observed after local light irradiation. Our results strongly suggest that hypericin holds promise as a new, safe, efficient and selective PDT photosensitizer.
对天然光敏剂金丝桃素的体内抗肿瘤活性进行了评估。将接种了A431细胞的无胸腺裸鼠腹腔注射不同剂量的金丝桃素,2小时后使用冷光源用白光(180 J/cm²)对肿瘤进行局部照射。当在肿瘤接种后一天开始治疗时,在接受光照治疗的动物中观察到剂量依赖性抗肿瘤作用。2.5 mg/kg金丝桃素可实现肿瘤生长的完全抑制。当研究单一剂量金丝桃素(5 mg/kg)继以单次光照治疗对已形成肿瘤(60 mm³)的疗效时,可见肿瘤质量减少80%。此外,局部光照照射后观察到A431异种移植瘤中有光敏剂蓄积。我们的结果强烈表明,金丝桃素有望成为一种新型、安全、高效且选择性的光动力疗法光敏剂。